Lensar Swings to $4.72M Q3 Loss After Profitable Q2
LNSR is trading near its 52-week low of $4.95 (13% above the low).
Summary
Lensar posted a $4.72 million net loss for the third quarter, a loss of 38 cents a share, a sharp reversal from the $3.5 million profit it reported for Q2 2026. Third-quarter revenue was $14.1 million, down 1% year over year, so the top-line momentum of Q2 did not hold. The swing matters for a company this small — the Q2 profit was driven by a $10 million merger termination fee and other one-time items in Q1, so the underlying business is back to burning money. Q2 revenue had grown 18% year-over-year to $16.5 million and beat consensus, making the Q3 decline the key contrast.
At the time of this announcement, LNSR was trading at $5.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $67.1M. The 52-week trading range was $4.95 to $12.94. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.